UID:
almahu_9948025240802882
Format:
1 online resource (590 p.)
Edition:
5th ed.
ISBN:
0-323-07477-4
Series Statement:
Secrets series
Content:
The new, 5th Edition of Endocrine Secrets, by Michael McDermott, MD, continues the tradition of the highly popular Secrets Series®. A two-color page layout, question-and-answer approach, and chapter containing the "Top 100 Secrets? offer a quick and current overview of essential knowledge in endocrinology. Updates throughout equip you with cutting-edge coverage, while new contributors present the latest perspectives. A wealth of user-friendly features-including valuable pearls, tips, and memory aids-help you to learn more efficiently. It all adds up to the perfect concise board review or handy
Note:
Description based upon print version of record.
,
Front Cover; Endocrine Secrets; Copyright Page; Dedication Page; Contents; Preface; Contributing Authors; Top 100 Secrets; I. Fuel Metabolism; Chapter 1: Diabetes Mellitus; 1. What is diabetes mellitus?; 2. What is the prevalence of diabetes?; 3. Is screening for type 1 diabetes recommended?; 4. Who should be screened for type 2 diabetes?; 5. How is diabetes diagnosed?; 6. What are the genetics of type 1 diabetes?; 7. What are the genetics of type 2 diabetes?; 8. Describe the pathogenesis of type 1 diabetes; 9. Describe the pathogenesis of type 2 diabetes; 10. Can diabetes be prevented?
,
11. What techniques are available to assess insulin resistance?12. Describe metabolic syndrome; 13. What causes beta-cell failure in type 2 diabetes?; 14. What are the standards of care for management of diabetes mellitus?; 15. Describe the current management approach to type 1 diabetes and the role of intensive therapy modeled by the Diabetes Control andComplications Trial (DCCT); 16. Is intensive diabetes therapy cost-effective?; 17. What is the United Kingdom Prospective Diabetes Study (UKPDS)?; 18. What is the current management approach with type 2 diabetes?
,
19. Based on the UKPDS and other studies, describe the optimal treatment for type 2 diabetes20. What are insulin analogs?; 21. What is inhaled insulin?; 22. What is amylin?; 23. What are incretins?; 24. How are incretins used to treat type 2 diabetes?; 25. What are the classes of oral diabetes medications? How do they work?; Bibliography; Chapter 2: Acute and Chronic Complications of Diabetes; 1. What are the acute complications of diabetes?; 2. Describe the symptoms of hyperglycemia; 3. What is DKA?; 4. What causes DKA?; 5. What illnesses may trigger DKA?
,
6. How can deficiencies in education trigger DKA?7. What are the signs and symptoms of DKA?; 8. How is DKA diagnosed?; 9. Is ketone testing always positive with DKA?; 10. What lab tests are recommended in the first hour of treatment for DKA?; 11. Summarize the strategy for fluid and potassium administration in the first hour; 12. How should insulin treatment be started with DKA?; 13. What assessments should be made in the second hour of treatment?; 14. Summarize the strategy for fluid and potassium administration in the second hour of treatment
,
15. How should insulin be adjusted during treatment?16. Summarize the basic strategy after the second hour of treatment; 17. When can the insulin infusion be discontinued?; 18. What other interventions may be necessary in the treatment of DKA?; 19. What is a possible complication of DKA? How should it be treated?; 20. What is hyperosmolar hyperglycemic syndrome?; 21. Who is at risk for HHS and why?; 22. What are the signs of HHS?; 23. Why is metabolic acidosis typically not seen in HHS?; 24. What are the symptoms of HHS?; 25. What is the most common presenting symptom of HHS?
,
26. List other possible causes of impaired mental status
,
English
Additional Edition:
ISBN 0-323-05885-X
Language:
English
